Approval · Notice of Compliance 1760 · 1999
TEVETEN: Notice of Compliance 1760
Issued August 25, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1760
- Date
- August 25, 1999
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin II receptor (at1) antagonist
Products in this notice
Medicinal ingredients
- EPROSARTAN MESYLATE 300 MG per TAB
- EPROSARTAN MESYLATE 400 MG per TAB